Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P by unknown
THE JOURNAL OF BIOLOGICAL CHEMISTRY 
0 1989 by The American Society for Biochemistry and Molecular Biology, Inc 
Vol. 264, No. 11, Issue of April 15, pp. 6202-6206,1989 
Printed in V.S.A. 
Guanine Nucleotide-sensitive  Interaction of a  Radiolabeled  Agonist 
with a  Phospholipase  C-linked  P2,-purinergic  Receptor* 
(Received for publication, November 11,1988) 
Christy L. Cooper#,  Andrew J. Morris,  and  T.  Kendall  Harden4 
From the Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 
Analogs of ATP  and  ADP  produce a guanine  nucleo- 
tide-dependent  activation of phospholipase C in  turkey 
erythrocyte membranes with pharmacological prop- 
erties  consistent  with  those  of a Pz,-purinergic  recep- 
tor  (Boyer, J. L., Downes, C. P., and  Harden, T. K. 
(1989) J. Biol. Chern. 264, 884-890). This  study de- 
scribes the interaction of adeno~ine-5’-0-2-thio[~~S] 
diphosphate ([35S JADPBS) with  this  putative  Pzy-puri- 
nergic receptor on purified plasma membranes pre- 
pared  from  turkey  erythrocytes.  In  binding assays per- 
formed  at 30 “C, the  association rate constant of [3sS] 
ADPDS was 1.1 X lo7 M“ min-’ and the dissociation 
rate  constant  was 3.8 X lo-’ min“. [3sS]ADPBS bound 
with high affinity ( K d  = 6-10 nM) to  an  apparently 
homogeneous  population of sites (E,,, = 2-4 pmol/mg 
protein). ATP and ADP analogs (2-methylthio ATP, 
ADPBS, ATP, ADP,  5”adenylyl  imidodiphosphate, 
a,B-methylene adenosine-5’-triphosphate, and B,y- 
methylene  adenosine  5’-triphosphate)  inhibited  the 
binding of [36S]ADPBS with  properties  consistent  with 
ligand  interaction  by  simple  law of mass  action  kinetics 
a t  a single  site.  The  rank  order of potency  for  inhibition 
of [3”S]ADP/3S binding was identical to the potency 
order  observed  for  these  same  agonists  for  stimulation 
of phospholipase C in  turkey  erythrocyte ghosts.  Gua- 
nine nucleotides inhibited [3sS]ADP/3S binding in a 
noncompetitive  manner  with the following  potency  or- 
der:  guanosine 5’-0-(3-thiotriphosphate) > 5’-gua- 
nylyl  imidodiphosphate > GTP = GDP > guanosine 5’- 
0-2-(thiodiphosphate). The data are consistent with 
the  idea  that [36S]ADPj3S may  be  used  to  radiolabel the 
Pzy-purinergic  receptor  linked  to  activation of phos- 
pholipase C in  turkey  erythrocyte  membranes. In ad- 
dition, interaction of radiolabeled agonist with the 
receptor  is  modified by guanine  nucleotides,  providing 
evidence  that  an  agonist-induced  receptor/guanine  nu- 
cleotide  regulatory  protein  complex  may be involved 
in  Pzy-receptor  action. 
Extracellular ATP and ADP interact with cell surface 
receptors to regulate a number of physiological processes, 
including  vascular  smooth muscle contraction, cardiac  func- 
tion, and platelet aggregation (1, 2). TWO general  classes of 
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purinergic  receptors  exist: PI-receptors are activated by aden- 
osine and are blocked by methylxanthines, whereas Pz-recep- 
tors are activated by ATP and ADP and are insensitive to 
methylxanthines (3). Recent  evidence  suggests that P2-puri- 
nergic  receptors can be further subdivided into Pax and Pz,, 
subtypes  on the basis of relative  potencies of synthetic ATP 
and ADP  analogs. The P2, subtype demonstrates a rank order 
of agonist  potency of 0,y-methylene ATP’ > a,p-methylene 
ATP > ATP = 2-methylthio ATP, whereas the Pzy subtype 
expresses a potency  order of 2-methylthio ATP >> ATP > 
a,@-methylene ATP = &y-methylene ATP (4). Although the 
inhibitory and stimulatory coupling of PI-purinergic receptor 
subtypes (A-1 and A-2 purinergic receptors) to adenylate 
cyclase has been widely studied (5), much less is known 
concerning the biochemical events involved in Pz-receptor 
action. However, it recently has been demonstrated that P2,.- 
purinergic  receptors stimulate phospholipase  C-catalyzed ino- 
sitol phosphate formation in hepatocytes (6, 7), endothelial 
cells (8, 9), and turkey erythrocytes (10). Moreover, a Pzy- 
purinergic receptor on turkey erythrocyte membranes has 
been  shown to stimulate the rate of activation of phospholi- 
pase C by guanine  nucleotides,  suggesting  involvement of a 
G-protein in Pa-receptor action (10). To date, a generally 
useful approach for directly studying P2-receptors has not 
been available. In the current study, we present data that 
support the idea that [35S]ADP/3S can be used to investigate 
the molecular  pharmacology of a phospholipase  C-linked,  G- 
protein-regulated P2,-purinergic  receptor. 
MATERIALS AND METHODS 
All of the adenine and guanine nucleotides were obtained from 
Boehringer Mannheim with the exception of GDP  and a,@-methylene 
ATP, AMP, and adenosine which  were purchased from Sigma and 2- 
methylthio ATP which was from Research Biochemicals (Natick, 
MA). UTP  and  CTP were obtained from Sigma. No. 30 glass fiber 
filters were from Schleicher & Schuell, and polypropylene test tubes 
were obtained from Sarstedt (Princeton, NJ). 2-[3H]myo-Inositol (15 
Ci/mmol) was obtained from American Radiolabeled Chemicals (St. 
Louis, MO). The sources of the other  materials used for the phospho- 
lipase C assay have been given previously (10). 
Synthesis of Radioligar~d-[~~S]ADP@S (specific activity = 1337 Ci/ 
mmol) was custom synthesized by Dr. Roger Shaw, Du Pont-New 
England Nuclear Research Products. [36S]ATPyS was first synthe- 
sized by the enzymatic thiophosphorylation of ADP (11). [36S]ADP@S 
’ The abbreviations used are: @,y-methylene ATP,  &y-methylene 
adenosine 5’-triphosphate; ADPPS, adenosine 5’-0-(2-thiodiphos- 
phate); 2-MeSATP, 2-methylthio adenosine 5’-triphosphate, 
App(NH)p, 5”adenylyl imidodiphosphate; a,@-methylene ATP, CY, 
@-methylene adenosine-5’-triphosphate; GTPyS, guanosine 5‘-0- 
(3-thiotriphosphate); Gpp(NH)p, 5”guanylyl imidodiphosphate; 
ATPaS, adenosine 5’-O-(l-thiotriphosphate); GDP@S, guanosine 5’- 
0-2-(thiodiphosphate); G-protein, guanine nucleotide-binding pro- 
tein; EGTA, [ethylenebis(oxyethylenenitrilo)Jtetraacetic acid; Hepes, 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid; ATPyS, adeno- 
sine 5’-0-3-thiotriphosphate. 
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then was prepared by incubating [35S]ATPyS (800-1500 Ci/mmol) 
with adenosine monophosphate and adenylate kinase (11). The [35S] 
ADP@ was greater than 99% chemically pure as determined by high 
performance liquid chromatography. It was stored in 10 mM Tricine, 
pH 7.6, containing 10 mM dithiothreitol at -70 "C for long term 
storage and  at -20 "C for routine usage. It was greater than 90% pure 
after 2  months of storage at -70 "C and could be repurified to >99% 
by anion exchange chromatography. 
Preparation of Turkey Erythrocyte Ghosts and Purified Plasma 
Membranes-Female turkeys weighing approximately 9-12 kg  were 
used, and no more than 20 ml of blood was  removed at any time in 
order to prevent development of reticulocytosis. In general the birds 
were bled every 1-2 weeks. Fresh blood  was obtained by venipuncture 
using a sterile heparinized syringe. For large scale preparation of 
purified plasma membranes, blood was obtained from Carolina Tur- 
keys (Mount Olive, NC). Freshly obtained cells were washed several 
times with Dulbecco's modified Eagle's  medium and  the buffy coat 
and leukocytes removed by aspiration.  Erythrocyte ghosts were pre- 
pared as previously described (12) after lysis of the cells in 5 mM 
sodium phosphate buffer containing 5 mM MgC12 and 1 mM EGTA, 
pH 7.4. 
Purified plasma membranes were prepared as follows. Washed, 
packed turkey erythrocytes were resuspended in an equal volume of 
ice-cold Dulbecco's modified Eagle's medium and placed in  the pres- 
sure chamber of a Parr cell disruption bomb (model 4635, Parr 
Instrument Co., Moline, IL). The chamber was filled with nitrogen 
to a pressure of 1100 psi. The bomb was maintained at 4 "C and  the 
cell suspension stirred continuously. After 30 min, the  contents were 
slowly discharged into  an equal volume of ice-cold buffer containing 
5 mM MgSOc 5 mM KH2P04,  pH 7.2, l  mM EGTA, 1 mM dithiothre- 
itol, 0.1 mM phenylmethylsulfonyl fluoride, and 0.1 mM benzamidine. 
The resultant suspension was centrifuged at 900 X g for 10 min at 
4 "C, and the supernatant was carefully removed. The pellet was 
resuspended in  the buffer described above and  the centrifugation step 
repeated. The  supernatants from these two steps were pooled and 
centrifuged at 10,000 X g, and  the pellet was resuspended in a t  least 
10 volumes of buffer containing 20 mM Tris, pH 7.2, 1 mM EDTA, 1 
mM dithiothreitol, 0.1 mM benzamidine, and 0.1 mM phenylmethyl- 
sulfonyl fluoride. This  step resulted in precipitation of any contami- 
nating nuclei which remained in the membrane preparation. Released 
DNA, which is insoluble in Mg-free buffer, was pelleted by centrifu- 
gation at  900 X g for 10 min. Purified turkey  erythrocyte membranes 
were recovered from the  supernatant by centrifugation at 10,000 X g 
for 10 min at 4 "C. This procedure routinely produced plasma mem- 
branes with a yield of 1.6-2.0 mg  of protein/ml of packed erythrocytes, 
a specific activity of the 8-adrenergic receptor of between 370-600 
fmol/mg protein and  an isoproterenol + GTP-stimulated adenylate 
cyclase activity of 100-110 pmol/min/mg protein. These values are 
comparable with those published by others for plasma membranes 
prepared following disruption of turkey  erythrocyte ghosts by soni- 
cation (13, 14) or by vigorous homogenization (15). 
A significant advantage of the above method is that  it can be easily 
scaled to process large volumes of cells. For example, the  starting 
volume of cells used to prepare plasma membranes for experiments 
reported in  this study varied from 5 ml to 8 liters, with similar extents 
of plasma membrane purification and recovery obtained. 
Assay of Phospholipase C Actiuity-Washed turkey  erythrocytes 
were labeled overnight with [3H]inositol (0.5-1.0 mCi) as described 
elsewhere (12). The phospholipase C assay was performed utilizing a 
previously described method (12) with the exception that  the assay 
buffer used in  the present  study  contained no MgClz. The reason for 
eliminating M F  in the assay buffers is discussed below. Guanine 
nucleotides or  guanine nucleotides and Pz,-receptor agonists mark- 
edly stimulate phospholipase C  in  turkey  erythrocyte ghost prepara- 
tions (10). However, this responsiveness, for reasons that so far have 
not been identified, is lost after plasma membrane purification. Thus, 
all tests of agonist stimulatory activity were made with the simple 
turkey  erythrocyte ghost preparation. 
Pa-receptor Binding Assay-Several considerations were made in 
the choice of a radioligand for the P2,-purinergic receptor. We wished 
to use an adenine nucleotide that would have a high affinity for the 
receptor and would undergo little  or  no hydrolysis during incubation 
with tissue. Unfortunately, a t  present  there is no selective P2-puri- 
nergic receptor antagonist available for use as a radioligand. There- 
fore, [Y3]ADP@S was chosen since it is the second most potent 
agonist for stimulation of inositol phosphate formation in turkey 
erythrocytes and is much less susceptible to hydrolysis compared to 
the most potent agonist, 2-MeSATP. An additional advantage of [35S] 
ADPpS is that  it can be labeled to a much higher specific activity 
(1337 Ci/mmol) than  tritiated adenine nucleotides. 
The binding assay was initiated by addition of a plasma membrane 
suspension of 10-50 pg of protein in 10 mM Hepes buffer, pH 7.4, to 
polypropylene tubes  containing [35S]ADPPS (0.1-200 nM) and various 
ATP or ADP analogs. The final assay volume  was  0.2  ml.  Following 
a 20-30 min incubation at  30 "C, 9 ml of cold  wash buffer (20 mM 
Tris, pH 7.5, 145 mM NaCl) was added to each tube. The samples 
were immediately filtered through glass fiber filters followed by 
another 9 ml  of cold wash buffer. Nonspecific binding was defined as 
the amount of ADPPS bound in the presence of 300 nM nonradioac- 
tive ADP@ except in the case of Scatchard analysis where 10 FM 
ADPPS was used to define nonspecific binding since concentrations 
of up to 200 nM [?S]ADPflS were  used. Nonspecific binding ranged 
from 5-14% of total binding. K; values for competing ATP  and ADP 
analogs were calculated using the method of Cheng and Prusoff (16) 
in which K; = IC,/l+ [SI/&, where IC60 is the concentration of 
competing ligand that inhibits 50% of specific binding, S is the 
concentration of [35S]ADPBS and Kd is the K d  of  [?3]ADPjj'S deter- 
mined independently by saturation binding isotherms. 
MgC12 (2 mM) was included in initial binding assays since it was 
assumed that  it might be important for observation of high affinity 
agonist binding. However, in the presence of MgC12, the binding of 
[35S]ADPj3S was not readily saturable suggesting that additional 
M$+-dependent adenine nucleotide-binding sites were labeled. Sub- 
sequent  experiments were performed in the absence of MgC1, since 
omission of M$+ from the assay buffer permitted observation of a 
saturable high affinity binding site for [35S]ADP@ in plasma mem- 
branes. Assuming that high affinity binding of  [35S]ADPj3S is to a  G- 
protein-linked receptor and  that binding follows properties similar to 
those of other G-protein-linked receptors (17), then  it is likely that 
tightly bound M%+ is not washed away during the preparation of 
membranes. Indeed, high affinity binding of [36S]ADP@S was almost 
completely lost in membranes that had been washed 4-5 times with 
10 mM EDTA. It is also notable that elimination of MgC12 from the 
binding assay was additionally beneficial in that it significantly 
reduced hydrolysis of ATP  and 2-methylthio ATP. 
&Adrenergic Receptor Binding Assay-"251-Cyanopindolol was used 
to  quantitate &receptors on  turkey  erythrocyte ghosts and/or plasma 
membranes as described previously (18). Nonspecific binding was 
defined using 10 p~ isoproterenol. '251-Cyanopindolol  was synthesized 
and purified as previously described (18). 
Protein Assay-Protein concentrations were determined using the 
method of Lowry et al. (19). 
RESULTS 
Measurement of p5S]ADP@S Binding to Purified Turkey 
Erythrocyte Plasma Membranes-Since the P2.,-purinergic 
receptor-mediated regulation of phospholipase C has been 
routinely assessed in erythrocyte ghosts (lo), we initially 
attempted to measure [35S]ADP@S binding  in  the  ghost  prep- 
aration. Although high affinity binding of radioligand was 
detected, the rank  order  of potency  observed  in  competition 
binding  studies did not fully  correspond to that observed  for 
the activation of phospholipase C. We subsequently  discov- 
ered that a number of the ATP analogs were hydrolyzed 
during a 20-min binding assay at 30 "C. In addition, the ghost 
preparation contains a substantial amount  of  contaminating 
non-plasma membrane material, predominantly nuclei, to 
which [35S]ADPPS also may bind. The competition curves 
obtained  with  various ATP and  ADP  analogs  generally 
spanned 3.5-4 orders of magnitude suggesting [35S]ADP@S 
interacted  with  multiple sites in the ghost  preparation. Fur- 
thermore, guanine nucleotides did not reproducibly inhibit 
[35S]ADP@S binding. Therefore, purified turkey erythrocyte 
plasma  membranes  were  prepared (see "Materials and Meth- 
ods"). The use  of these membranes  in the [35S]ADPPS binding 
assay alleviated the potential problems  discussed  above. 
[35S]ADP@S binding to plasma  membranes  was  performed 
at 30 "C as described  under  "Materials  and  Methods."  Binding 
of [35S]ADP@S (1 nM) reached steady state within approxi- 
mately 20 min at 30 "C (data not shown). The association 
rate constant was 1.1 X lo7 M" min" (Fig. lA). Addition of 
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FIG. 1. A, time course of association of [36S]ADPPS with the Pz,- 
purinergic receptor in turkey erythrocyte plasma membranes. Plasma 
membranes (25 pg  of protein) were incubated for the indicated times 
at 30 “C in the presence of 1 nM [3sS]ADPpS. Data are presented as 
a semilog plot where  ln[DR].,/([DR], - [DR]) is the  natural log of 
the amount of [3sS]ADPPS specifically bound at equilibrium divided 
by the amount specifically bound at equilibrium minus the amount 
specifically bound at  the indicated time in min. The  data are repre- 
sentative of results obtained in three separate experiments. B, time 
course of dissociation of [35S]ADPflS from turkey erythrocyte plasma 
membranes. Plasma membranes (25 pg  of protein) were incubated at 
30 “C with 1 nM [35S]ADPpS for 20 min, and  then 300 nM nonradioac- 
tive ADPDS was added to initiate dissociation of [3sS]ADPBS. Data 
are presented as a semilog plot where In DR/DR, is the  natural log 
of the [36S]ADP(3S specifically bound at  the indicated time divided 
by the [35S]ADPPS specifically bound immediately prior to  the addi- 
tion of nonradioactive ADPPS. The  data are representative of results 
obtained in two experiments. 
T l M E  (mill) 
300 nM ADPpS resulted in  rapid dissociation of radioligand. 
Dissociation was with a single component and with a rate 
constant of 3.8 X lo-* min” (Fig. 1B). A kinetically derived 
K d  of approximately 4.0 nM was obtained in two separate 
experiments. Binding of [35S]ADPpS was saturable  and  ap- 
parently occurred to a single class of high affinity binding 
sites (Fig. 2). A & value of 8.5 f 0.5 nM and &ax of 3.05 & 
0.42 pmol/mg was obtained by Scatchard  transformation of 
saturation binding isotherms (n = 5). [“S]ADP@S binding 
activity copurified during the membrane purification with p- 
adrenergic receptors, detected using ‘261-cyanopindolol (Table 
I),  and was predominately associated with the purified plasma 
membrane rather than nuclear fraction. The density of p- 
adrenergic receptors in  the purified plasma membrane frac- 
tion was approximately 6-fold higher than the density of 
receptors detected in the ghost preparation. As discussed 
previously, the existence of nonreceptor-binding sites for [35S] 
ADPgS in ghosts made it difficult to measure confidently the 
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FIG. 2. Scatchard analysis of [36S]ADPflS binding to turkey 
erythrocyte membranes. Plasma membranes (33 pg of protein) 
were incubated with increasing concentrations of [“SIADPBS  (0.1- 
200 nM) as described under “Materials and Methods.” Nonspecific 
binding was defined with 10 p~ ADP@. Data are  plotted as fmol of 
radioligand specifically bound (abscissa)  versus bound ligand divided 
by free ligand concentration (ordinate). The  data are representative 
of results obtained with five different membrane preparations. 
TABLE I 
Comparison of /3-adrenergic receptor (BAR) and  Pw-purinergic 
receptor (PDR) binding activities  during the preparation of turkey 
erythrocyte  plasma  membranes 
All data are normalized to 1 ml of packed turkey erythrocytes. 8- 
Adrenergic receptors were assayed using 1*61-cyanopindolol. Eryth- 
rocyte ghosts were prepared by hypotonic lysis of turkey red blood 
cells as previously described (12). The nuclear and plasma membrane 
fractions were obtained by differential centrifugation following dis- 
ruption of erythrocytes by nitrogen cavitation as described under 
“Materials and Methods.” 
Protein BAR richment Fold en- P%R 
% Recovery 
BAR  PwR 
fmll fmll 
Erythrocyte ghosts 18.84 76 410 
Nuclear fraction 11.8 25  0.29 146  2 22 
Membrane fraction 1.5 459 6.0 2310 50 46 
w mg 
of P2y-receptors in the plasma membrane preparation is not 
given. 
Comparison of Binding Affinities with Apparent Affinities 
for Activation of Phospholipase C-The binding of [36S] 
ADP@S was inhibited  in  a  concentration-dependent  manner 
by ADP and  ATP analogs (Fig. 3). Inhibition followed  law  of 
mass action kinetics for interaction at a single site, i.e. Hill 
coefficients were approximately unity  (data  not shown), and 
the order of potency for inhibition was consistent with that 
previously suggested for a P2,-purinergic receptor. As  we 
previously reported (lo), ATP and ADP analogs produce a 
marked stimulation of inositol phosphate formation in  turkey 
erythrocyte ghosts in  the presence of guanine nucleotides. In 
the present study, the inositol phosphate assay was performed 
in the absence of added M$+ to more closely approximate 
conditions used in  the [35S]ADP@S binding assay. The overall 
rank potency order for stimulation of phospholipase C was 
not changed by performing the assay in  the absence of added 
M e ;  however, the concentration-response curves for several 
of the ATP analogs were shifted slightly to  the left,  presum- 
ably due to less hydrolysis by ATPases  present  in the ghost 
preparation  (data  not shown). A comparison of KO, values for 
the same agonists for stimulation of phospholipase C and Ki 
values for inhibition of [3SS]ADP@S binding is  illustrated  in 
Table 11. The potency order of the ATP/ADP analogs for 
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FIG. 3. Concentration-dependent  competition of [“SI 
ADPOS binding by ATP  and  ADP analogs. Plasma membranes 
(10-15 pg) were incubated as described under “Materials and  Meth- 
ods” in the presence of 0.5 nM  [3’SS]ADPf3S and various concentrations 
of 2-MeSATP (W); ADPpS (0); ADP (0); ATP (0); App(NH)p (A); 
n,&methylene ATP (a,p-MeATP) (X); P,y-methylene ATP (P,y 
MeATP) (VI. Data are expressed as a percent of maximal binding. 
Individual competition curves represent the mean of three  to four 
different experiments performed in duplicate for each analog. 
TABLE I1 
Comparison of the KO, and K, values of various P,-purinergic 
receptor agonists 
KO, values represent data obtained in phospholipase C activity 
assays in erythrocyte ghosts in the presence 0.5 mM GTP (column 2) 
or 1 p~ GTP-yS (column 3 ) .  Ki values were obtained from competition 
binding curves (n  = 3 ) .  
Agonist K0.s (GTP) K0.s (GTPrS) Ki 
2-MeSATP 101 f 10 nM 9.8 f 1.2 nM 10.2 f 1.5 nM 
ADPPS 
ATP 
331 f 21 nM 31 f 2.3  nM  33.2 f 2.0 nM 
ADP 
1.0 f 0.2 p M  105 f 6.8 nM 101 f 2.0 nM 
1.1 f 0.2 p M  131 f 10 nM 140 f 16 nM 
App(NH)p 5.0 f 0.4 pM 401 f 24 nM 334 f 21 nM 
Q-MeATP 28 f 2.0 pM 3.5 f 0.1 p M  4.1 f 0.4 p~ 
P,r-MeATP 95 f 12 GM 9.5 f 0.3 LLM 16 f 3.2 GM 
inhibition of [”S]ADP@S binding was identical to  that ob- 
served in inositol phosphate assays, and  there was a very close 
agreement between the KO.& values obtained for the activation 
of phospholipase C in  the presence of 5 p~ GTPyS and  the 
Ki values obtained in competition binding studies. KO.& values 
for the activation of phospholipase C obtained using 0.5 mM 
GTP were approximately one order of magnitude greater than 
the Ki values determined for agonists in competition binding 
assays. 
Effect of Guanine Nucleotides  on p5Ss/ADPflS Binding to 
Plasma Membranes-Inositol phosphate formation in re- 
sponse to P,-receptor agonists is  dependent on the presence 
of guanine nucleotides in erythrocyte membranes (lo), sug- 
gesting that Pz-receptors couple to a guanine nucleotide- 
binding protein. As illustrated in Fig. 4, guanine nucleotides 
reduced the binding of [35S]ADP@S and displayed a rank 
potency order similar to  that observed for other receptors 
coupled to G-proteins; i.e. GTPyS > Gpp(NH)p > GTP = 
GDP 7 GDPpS. GMP, cytidine triphosphate, and uridine 
triphosphate  had no effect on the binding of [35S]ADPflS at 
concentrations less than 100 pM. 
To rule out  the possibility that guanine nucleotides inhibit 
binding due to a  direct competition for a receptor-binding site 
rather  than due to action on a  GTP-binding  protein,  inhibi- 
tion curves for guanine nucleotides were generated using three 
different [35S]ADPPS concentrations (0.1, 1.0, and 10 nM). If 
guanine nucleotides were capable of directly competing with 
[35S]ADPpS at  its binding site,  then the inhibition curve for 
o ! , , , , , , , , , , , , , , ,  
-10 -9 -8 -7 46 -5 -4 -3 
LOG NUCLEOTIDE (M) 
FIG. 4. Concentration-dependent inhibition of IS6S]ADPBS 
binding by guanine nucleotides. Plasma membranes were incu- 
bated as described under “Materials and Methods” with [3’S]ADP(3S 
(1 DM) in the presence of various concentrations of GTPyS (m); 
(0); UTP (+). Individual curves represent the mean of three experi- 
ments performed in duplicate for each analog. Data  are expressed as 
a  percent of maximal binding of [3sS]ADPPS, and nonspecific binding 
was defined with 300 nM ADPBS. 
G ~ ~ ( N H ) P  (n); GTP (0); GDP (0); GDPSS (A); GMP (X); CTP 
2o i 
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FIG. 5. GTP-yS inhibition curves obtained in the presence 
of three different concentrations of [36S]ADPBS. Plasma mem- 
branes (10-20 pg of protein) were incubated as described under 
“Materials and Methods” with either 0.1 nM (H), 1.0 nM (El), or 10 
nM (0) [35SIADPfiS in the presence of various concentrations of 
GTPyS. Individual GTPyS inhibition curves represent the mean of 
three experiments performed in duplicate for each concentration of 
GTPyS. 
guanine nucleotides should shift to  the right in the presence 
of increasing concentrations of radioligand. However, as is 
shown in Fig. 5, no rightward shift in the  GTPyS inhibition 
curve was observed indicating that  the inhibitory effect of 
GTPyS is noncompetitive in nature. In contrast, ATPyS 
displacement curves were shifted to  the right as  the concen- 
tration of radioligand increased (data  not shown). The rate of 
dissociation of [35S]ADP@S was increased by %fold by the 
addition of GTPyS, again suggesting that guanine nucleotides 
do not act by simple competition at the level of the Pzy- 
purinergic receptor (data  not shown). Further evidence that 
GTPyS  has no direct effect on the Pz,-receptor  was provided 
by the observation that  GTPyS did not stimulate inositol 
phosphate production in intact  turkey erythrocytes except at 
high concentrations  (data  not shown). Taken together, these 
data strongly suggest that  the purinergic receptor labeled by 
[35SJADP/3S is regulated by guanine nucleotides, thus sup- 
porting  other  data  illustrating that Pzy-receptor agonists stim- 
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ulate inositol phosphate formation by a guanine nucleotide- 
dependent mechanism. 
DISCUSSION 
Pz-purinergic receptors have major physiological signifi- 
cance, but little biochemical information is available concern- 
ing their properties. Understanding the molecular nature of 
these receptors requires development of approaches for their 
direct quantitation,  and the  data presented above  suggest that 
[35S]ADPPS can be readily used for this purpose. [35S]ADPpS 
binds with high affinity to  an  apparent single class of binding 
sites on turkey erythrocyte membranes; the density of these 
sites is within the range previously observed for other phos- 
pholipase C-linked receptors. Competition binding studies 
with a series of ATP and ADP analogs suggest that  the Pz- 
receptor labeled by [35S]ADP@S is one of the PZ,-receptor 
subtype. Moreover, the potency order of agonists observed in 
competition binding assays was identical to  that for stimula- 
tion of inositol phosphate production, suggesting that the 
binding site detected by [35S]ADP@S corresponds to  the Pzy- 
receptor that regulates phospholipase C-catalyzed inositol 
phosphate production. High affinity binding of [35S]ADPpS 
was sensitive to guanine nucleotides which is  consistent with 
the idea that the Pzy-receptor stimulates phospholipase C 
through interaction with a G-protein. 
It was not possible to perform the [35S]ADP/3S binding 
assays and the assay for phospholipase C under identical 
conditions. That is, the receptor binding assay was carried 
out in a plasma membrane preparation due to the existence 
of a high density of binding sites  in erythrocyte ghosts that 
are  apparently  unrelated to  the Pzy-receptor, and we were not 
able to measure phospholipase C-catalyzed inositol phosphate 
formation in the purified plasma membranes. The reason for 
the lack of hormone responsiveness in the purified membranes 
is unclear. These turkey erythrocyte membranes possess a 
PZy-receptor that is apparently coupled to the relevant G- 
protein (Fig. 4) and also contain the substrate phosphatidyl 
inositol 4,5-bisphosphate in amounts similar to  that present 
in erythrocyte ghosts. In addition, a phospholipase is present 
in these membranes that can be measured using exogenously 
provided [3H]phosphatidylinosit~l 4,5-bisphosphate? There- 
fore, a possible explanation for the lack of hormone respon- 
siveness in  the membranes uerstts ghosts is that preparation 
of the membranes by nitrogen cavitation disrupts the capacity 
of phospholipase C to  interact with its  substrate phosphatidyl 
inositol 4,Ei-bisphosphate. Despite the disparate membrane 
preparations, the Ki values for a series of agonists for binding 
were in good agreement with K0.5 values for the same agonists 
determined in inositol phosphate assays in  the presence of 
GTP and were essentially identical to the Koa values for 
activation determined in  the presence of GTPyS.  This abso- 
lute agreement with apparent affinities determined in the 
presence of GTPrS may  be  more fortuitous than instructive, 
in that due to  the lag observed in activation of phospholipase 
C by GTPrS in turkey erythrocyte membranes, concentration 
effect curves generated by measuring accumulation of inositol 
phosphates are shifted to  the left with increasing times of 
incubation (10). 
Previous attempts  to radiolabel the Pzy-purinergic receptor 
have met with difficulty primarily due to  the lack of a high 
* A .  J. Morris and T. K. Harden, unpublished observations. 
affinity radioligand that possesses a high specific activity. In 
addition, there  are numerous binding sites for adenine nucle- 
otides as well as enzymes that degrade ATP. [%]ADP@S is 
relatively resistant to hydrolysis in turkey  erythrocyte mem- 
branes  and was the second most potent of the agonists tested 
for  stimulation of phospholipase C. Furthermore, it can be 
labeled to very high specific activity (1337 Ci/mmol). Both 
[3H]ATP  and  [3H]App(NH)p have been used without success 
in attempts  to label P2-receptors (20, 21). Keppens and 
DeWulf (22) have used [35S]ATPaS in an  attempt to label 
the Pz-receptor linked to glycogenolysis in hepatocytes. Al- 
though high affinity binding of radioligand was detected in 
intact hepatocytes as well as membranes, there was a large 
component of binding that was nonsaturable,  and the number 
of supposed specific binding sites detected by [35S]ATPaS 
was surprisingly high (30 pmol/mg protein; 3,000,000 sites/ 
cell) for a physiologically relevant cell surface receptor. 
The G-protein that regulates phospholipase C in turkey 
erythrocytes and other target tissues thus far has eluded 
identification. The evidence for its existence and only means 
of detection in the turkey erythrocyte membrane has been 
based on guanine nucleotide dependence of phospholipase C 
for activation (10,12,23). Since  PPY-receptor agonists promote 
guanine nucleotide-mediated activation of the enzyme, the 
effects of guanine nucleotides on  [35S]ADP/3S binding almost 
certainly are  a consequence of Pzy-receptor agonist-induced 
association of the receptor and  the phospholipase C-linked 
G-protein. As such, the ability to now directly measure a 
guanine nucleotide-sensitive state of the Pzy-receptor will 
allow for further dissection of the mechanism whereby inter- 
action of the PzY-receptor/G-protein/phospholipase C-signal- 
ing system is promoted by adenine nucleotides. 
Acknowledgments-We are grateful to Carolina Turkeys, Mount 
Olive, NC, for supplying unlimited quantities of turkey blood. We 
thank Jose Boyer for helpful discussions and continual encourage- 
ment and Gary  Waldo  for help in preparation of plasma membranes. 
We also wish to thank Mohe Tanner for typing this manuscript. 
REFERENCES 
1. Fleetwood, G., and Gordon, J. L. (1987) Br. J. Phormacol. 90, 219-227 
2. Gordon, J. L. (1986) Eiochem. J. 233,309-319 
3. Williams, M. (1987) Annu. Reu. Phormacol. Toxicol. 27, 315-345 
4. Burnstock, G., and Kennedy, C. (1985) Gen. Phnrmucol. 16,433-440 





8. Forsberg, E. 
262,1348 
Natl. Acad. Sci. U. S. A. 84. 5 
)-15794 
, R., Blackmore, P. F.,  and  Exton, J.  H. (1985) J. Eiol. Chem. 2 6 0 ,  
1, F., Tokumitsu, Y., Kondo, Y., and Ui, M. (1987) J. Biol. Chem. 
#3-13490 
J., Feuerstein, G., Shohami, E., and Pollard, H. B. (1987) Proc. 
9. Pirotton, S., &s e, E ,  Demolle, D., Erneux, C., and Boeynaems, J.-M. 
10. Boyer, J. L., Downes, C. P., and Harden, T. K. (1989) J.  Biol. Chem. 2 6 4 ,  
630-5634 
(1987) J. Biol. !hem: 2 6 2 ,  17461-17466 
m4-890 
11. Goodv. R. S., Eckstein, F..  and Schirmer, R.  H.  (1972) Biochem. Bioahvs. 
". ."
Acta 276,'155-161 
P.  (1987) Btochem. J. 252,583-593 
.  . .  . .
12. Harden, T. K.! Hawkins, P. T., Stephens,  L., Boyer, J. L., and Downes, C. 
13. Beam. D. G.. Aluer. S. L.. Palade. G. E.. and Greeneard, P.  (1979) J. Cell 
Bioi 8 3 , i - l j  . ' 
- . . . 
14. Pike, L. J., and Lefkowitz, R. J. (1980) J. Biol. Chem. 14,6860-6867 
15. Pedersen, S., and Ross, E. M. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 
16. Cheng, Y. and Prusoff, W.  H.  (1973) Biochem. Phormacol. 22,3099-3108 
17. Korn, S. J., Martin, M. W., and Harden, T. K. (1983) J. Phormacol. Exp. 
18. Witkin, K. M.,  and Harden, T. K. (1981) J.  Cyclic Nucleotide Res. 7 ,  235- 





18. Witkin, K. M.,  and Harden, T. K. (1981) J.  Cyclic Nucleotide Res. 7 ,  
18. Witkin, K. M.,  and Harden, T. K. (1981) J.  Cyclic Nucleotide Res. 7 ,  
18. Witkin, K. M.,  and Harden, T. K. (1981) J.  Cyclic Nucleotide Res. 7 ,  
Lowry, 0. H., Rosebrough, N. 
Lowry, 0. H., Rosebrough, N. 
18. Witkin, K. M.,  and Harden, T. K. (1981) J.  Cyclic Nucleotide 
